NBM

EQS-News: Allianz SE: Allianz achieves record operating profit and shareholders’ core net income

Retrieved on: 
수요일, 3월 13, 2024
Acquisition, Financial instrument, Solvency, CSM, Management, Asset management, Growth, Roe, Health, Insurance, Policy, CIR, Finance, Economics, NBM, EPS, VNB, Internal

“Allianz extended our track record of delivering a record operating profit and core net income, consolidating our leading position as one of the world’s most resilient global insurers and active asset managers.

Key Points: 
  • “Allianz extended our track record of delivering a record operating profit and core net income, consolidating our leading position as one of the world’s most resilient global insurers and active asset managers.
  • Shareholders’ core net income increased to 2.4 (1.6) billion euros due to a higher operating profit and non-operating result.
  • 3 Core EPS and core RoE calculation based on shareholders‘ core net income.
  • “We’ve achieved another year of record results and all operating segments finished the year above or close to their operating profit target mid-points.

NEO Battery Materials Increases Share Ownership of South Korean Subsidiary – NBM Korea Co.

Retrieved on: 
월요일, 1월 29, 2024
Silicon, Car, Certification, Transaction, SME, NBM, A&P, Indian stock exchange, NEO, CAD, Ministry

TORONTO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTCQB: NBMFF)

Key Points: 
  • TORONTO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTCQB: NBMFF)
    NEO Battery Materials Ltd. (“NEO” or the “Company”), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, announces that the Company has increased its ownership of the South Korean subsidiary, NEO Battery Materials Korea Co., Ltd. (“NBM Korea”), through a Share Purchase Agreement (the “Agreement”) with Automobile & PCB Inc (“A&P”).
  • NEO acquired 258,829 Common Shares of NBM Korea from A&P for an aggregate purchase price of $1,708,707 CAD (the “Transaction”).
  • Preceding the Transaction, the Company directly held 776,487 Common Shares of NBM Korea, representing 60% of the issued and outstanding shares of NBM Korea, and following the closing, NEO now directly holds 1,035,316 Common Shares, representing 80% of the issued and outstanding shares of NBM Korea.
  • Furthermore, NBM Korea is actively discussing with several South Korean venture capital and institutional funds for further expansion and scale-up funding for the silicon anode business and value-enhancing battery technology projects.

EQS-News: Allianz increases revenues by 4.5% to 36.5 billion euros - Group affirms full-year outlook

Retrieved on: 
목요일, 12월 28, 2023
Roe, 3Q, Solvency, CSM, Economics, Trust, NBM, Asset management, Alpha, VOYA, Insurance, Allianz, Financial instrument, CIR, Growth, Internal, Finance, VNB, EPS, Environment, Chemical

We confirm with confidence our operating profit target of 14.2 billion euros, plus or minus 1 billion euros.

Key Points: 
  • We confirm with confidence our operating profit target of 14.2 billion euros, plus or minus 1 billion euros.
  • Favorable foreign currency translation effects of 34.4 billion euros and net inflows of 10.5 billion euros were largely offset by market effects of 37.1 billion euros.
  • 9M 2023: Operating revenues decreased by 5.9 percent to 5.8 billion euros mainly as a result of lower AuM-driven revenues.
  • Third-party assets under managementwere 1.670 trillion euros as of September 30, 2023, up by 35 billion euros from the end of 2022.

Allianz Increases Operating Profit by 7.1% to 3.8 Billion Euros

Retrieved on: 
목요일, 8월 10, 2023
Asset Management, Professional Services, Insurance, Finance, Williams v Natural Life Health Foods Ltd, Asset management, VNB, Allianz, CIR, Property, Property & Casualty Management Systems, Multimedia, Solvency, Financial instrument, NBM, Growth, CSM, Roe, EPS, Internal, Economics, Economy of the Egyptian Armed Forces, Financial services, Gasoline, Clothing, Chemical, Bank, Renewable energy, Marketing, Security (finance), Transformer, Textile

View the full release here: https://www.businesswire.com/news/home/20230809567686/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230809567686/en/
    Chief Executive Officer of Allianz SE (Photo: Allianz SE)
    Operating profit increases 7.1 percent to 3.8 billion euros; strong performance particularly in Life/Health and Property-Casualty business segments
    Operating profit increases 14.9 percent to 7.5 billion euros: primarily driven by Life/Health and Property-Casualty business segments
    Excellent Solvency II capitalization ratio of 208 percent, compared with 201 percent at the end of 4Q 20221
    2023 operating profit target confirmed at 14.2 billion euros, plus or minus 1 billion euros2
    Share buy-back of up to 1.5 billion euros on track: 2.9 million shares acquired for 0.6 billion euros until the end of July 2023.
  • We confirm our full-year outlook of operating profit of 14.2 billion euros, plus or minus 1 billion euros.”
    2Q 2023: Total business volume rose by 8.0 percent to 17.6 (16.3) billion euros.
  • Operating profit rose 16.3 percent to 3.9 (3.3) billion euros, driven by a significantly higher operating insurance service result and an improved operating investment result.
  • Positive net inflows of 2.7 billion euros and favorable market impacts of 2.0 billion euros were offset by negative foreign currency translation effects of 10.5 billion euros.

EQS-News: Allianz SE: Allianz increases operating profit by 7.1% to 3.8 billion euros - Group affirms full-year outlook

Retrieved on: 
목요일, 8월 10, 2023
Williams v Natural Life Health Foods Ltd, Asset management, VNB, Insurance, CIR, Property, Property & Casualty Management Systems, Finance, Solvency, Financial instrument, NBM, Allianz, Growth, CSM, Roe, EPS, Internal, Economics, Economy of the Egyptian Armed Forces, Security (finance), Financial services, Gasoline, Clothing, Chemical, Bank, Renewable energy, Marketing, Transformer, Textile

2Q 2023: Operating profit increased 7.1 percent to 3.8 (2Q 2022: 3.5) billion euros.

Key Points: 
  • 2Q 2023: Operating profit increased 7.1 percent to 3.8 (2Q 2022: 3.5) billion euros.
  • Shareholders’ core net income was strong at 2.5 (2Q 2022: 2.0) billion euros due to a higher operating profit.
  • We confirm our full-year outlook of operating profit of 14.2 billion euros, plus or minus 1 billion euros.”
    2Q 2023: Total business volume rose by 8.0 percent to 17.6 (16.3) billion euros.
  • Positive net inflows of 2.7 billion euros and favorable market impacts of 2.0 billion euros were offset by negative foreign currency translation effects of 10.5 billion euros.

Game-changing Indian MRI Scanner Launched: Targets 6 billion People without Access to Cutting-edge Imaging Technologies

Retrieved on: 
월요일, 8월 7, 2023
Department of Biotechnology, Magnetic resonance, Prevalence, MOS, Biotechnology, Employment, Research, DBT, Government of India, USD, Government, MRI, NBM, Access, Conditional sentence, Magnetic resonance imaging, PMO, Ecosystem, Transport, Computer science and engineering, Biotechnology industry in China, Independent, World Health Organization, Medical imaging, Pension

NEW DELHI, Aug. 7, 2023 /PRNewswire/ -- In a groundbreaking development, India-based company Voxelgrids has launched an advanced and affordable MRI scanner with the potential to revolutionize healthcare accessibility not only in India but also worldwide. With funding from BIRAC (Biotechnology Industry Research Assistance Council), an institution set up by the Department of Biotechnology (DBT), Government of India, to nurture and promote biotechnology innovations and industry in India, Voxelgrids has successfully developed a cutting-edge MRI (Magnetic Resonance Imaging) scanner that is significantly more affordable than traditional counterparts, breaking down barriers to access for billions of people previously unable to afford the procedure.

Key Points: 
  • Game-changing Indian MRI Scanner Launched: Targets 6 billion People without Access to Cutting-edge Imaging Technologies
    The global MRI equipment industry reached USD 7.08 billion in 2022, and is projected to grow to USD 11.50 billion by 2030, exhibiting a CAGR of 6.3% during the forecast period.
  • Although the global MRI industry has grown significantly, a staggering 70 percent of the world's population still lacks access to MRI machines.
  • Addressing this challenge, an Indian company has introduced an affordable MRI scanner, offering cost benefits of up to USD 800,000 compared to the conventional models.
  • The low-cost MRI scanner is set to transform the healthcare landscape, empowering healthcare providers to serve diverse communities and drive positive health outcomes globally.

Allianz Increases Operating Profit by Almost a Quarter to 3.7 Billion Euros

Retrieved on: 
금요일, 5월 12, 2023
Professional Services, Insurance, Business, Finance, Asset management, VNB, Allianz, Williams v Natural Life Health Foods Ltd, CIR, Multimedia, Solvency, Financial instrument, NBM, CSM, Roe, EPS, Internal, Engineered wood, Chemical, Gasoline, Clothing, Financial adviser, Bank, Financial services, Security (finance)

1Q 2023: Operating profit jumped 24.2 percent to 3.7 (1Q 2022: 3.0) billion euros.

Key Points: 
  • 1Q 2023: Operating profit jumped 24.2 percent to 3.7 (1Q 2022: 3.0) billion euros.
  • We confirm our full-year outlook of operating profit of 14.2 billion euros, plus or minus 1 billion euros.”
    1Q 2023: Total business volume rose by 11.2 percent to 24.1 (21.7) billion euros.
  • Operating profit surged by 22.7 percent to 1.9 (1.5) billion euros, due to a higher operating insurance service result that was partly offset by a slightly lower operating investment result.
  • Positive net inflows of 14.9 billion euros and favorable market impacts of 42.2 billion euros were partially offset by negative foreign currency translation effects of 23.4 billion euros.

EQS-News: Allianz SE: Allianz increases operating profit by almost a quarter to 3.7 billion euros

Retrieved on: 
금요일, 5월 12, 2023
Asset management, VNB, Insurance, Williams v Natural Life Health Foods Ltd, CIR, Property & Casualty Management Systems, Finance, Solvency, Financial instrument, NBM, Allianz, CSM, Roe, EPS, Internal, Security (finance), Chemical, Gasoline, Clothing, Financial adviser, Bank, Financial services

1Q 2023: Operating profit jumped 24.2 percent to 3.7 (1Q 2022: 3.0) billion euros.

Key Points: 
  • 1Q 2023: Operating profit jumped 24.2 percent to 3.7 (1Q 2022: 3.0) billion euros.
  • We confirm our full-year outlook of operating profit of 14.2 billion euros, plus or minus 1 billion euros.”
    1Q 2023: Total business volume rose by 11.2 percent to 24.1 (21.7) billion euros.
  • Operating profit increased to 1.3 (0.8) billion euros and benefited in particular from a higher result in the United States.
  • Positive net inflows of 14.9 billion euros and favorable market impacts of 42.2 billion euros were partially offset by negative foreign currency translation effects of 23.4 billion euros.

EIP Pharma Announces Presentation of Neuroimaging Data Exhibiting Potential Effects of Neflamapimod on Cholinergic Structure and Function at AD/PD™ 2023

Retrieved on: 
월요일, 4월 3, 2023
Nucleus, Neuron, International Conference on Information Systems Security and Privacy, Atrophy, Alzheimer's disease, EOT, Swedish Exhibition & Congress Centre, NBM, Basal forebrain, Biomarker, DGM, MRI, Magnetic resonance imaging, MD, AD, Conference, Structure, MAP, Medical imaging, Neuroscience, Anatomy, Patient

BOSTON, April 3, 2023 /PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced the oral presentation by academic investigators from the Amsterdam University Medical Center of neuroimaging results from a phase 2a clinical study in patients with early Alzheimer's disease (AD) at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™) 2023, which took place virtually and in person March 28 – April 1, 2023, in Gothenburg, Sweden.

Key Points: 
  • Structural and MRI assessments had been conducted at baseline and following 12 weeks of treatment with neflamapimod.
  • The potential regression of atrophy and recovery of function in neflamapimod-treated patients in this study suggests a restoration of cholinergic neurons in the NbM and are supportive of data generated in previous preclinical studies that demonstrated neflamapimod reversed the neurodegenerative process in the basal forebrain cholinergic system.
  • "We are encouraged by these findings and are pleased to share these important results with the medical and scientific community."
  • Title: Effects of the p38-Alpha Kinase Inhibitor Neflamapimod on the Basal Forebrain in Patients, Assessed by Structural MRI
    Speaker: Chen-Pei Lin, Department of Anatomy and Neurosciences, Amsterdam University Medical Center
    Location: Gothenburg, Sweden (Swedish Exhibition & Congress Centre; Hall F4+F5)

For the First Time The Tel Aviv Stock Exchange (TASE) Regulates Crypto Trading: Non-Banking Members will Allow their Customers to Transact in Cryptocurrency

Retrieved on: 
월요일, 2월 27, 2023
Crypto, Financial services, Bank of Israel, State, Digital asset, Ministry, NBM Publishing, European, Tel Aviv Stock Exchange, NYDFS, FATF, Capital Markets Authority of Kenya, BitLicense, NBM, Financial Action Task Force, New York State Department of Financial Services, South Korean International Monetary Fund Agreement, 1997, TEL, Ministry of Finance (Israel), Policy, Bank, Chief economist, Capital market, International Monetary Fund, Israel Securities Authority, NIS, TASE, Fiat, Cryptocurrency

TEL AVIV, Israel, Feb. 27, 2023 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) publishes today a draft for public comments for approval of the expansion of the authorized activities of Non-Banking Members (NBMs) to include trading in Cryptocurrency.

Key Points: 
  • The Cryptocurrency market has experienced turmoils over the past year, which have brought material changes in Crypto activity, as more regulated institutions take part in this activity.
  • This requires regulation that will mitigate the various risks (operational, legal, cyber and other) that are inherent in Cryptocurrency activity.
  • Within this framework, TASE proposes an amendment to the TASE Rules that will permit NBMs to allow their customers to transact in Cryptocurrency.
  • Upon receipt of comments from the public, the proposal will be submitted for approval by the TASE Board of Directors.